Efficiency of chlorhexidine–silver sulfadiazine-impregnated venous catheters at subclavian sites

0

Reference:

Lorente, L., Lecuona, M., Jiménez, A., Lorenzo, L., Santacreu, R., Ramos, S., Hurtado, E., Buitrago, M. and Mora, M.L. (2015) Efficiency of chlorhexidine–silver sulfadiazine-impregnated venous catheters at subclavian sites. American Journal of Infection Control. April 30th. [epub ahead of print].

Reference:

Background: Cost-effectiveness analyses show that chlorhexidine–silver sulfadiazine (CHSS)-impregnated catheters reduce catheter-related bloodstream infection (CRBSI) and central venous catheter (CVC)-related costs. However, no studies have reported the efficiency of CHSS-impregnated catheters for venous access when the risk of CRBSI is low; for example, at the subclavian site. This study determined the cost of a CVC, diagnosis of CRBSI, and antimicrobial agents to treat CRBSI; we did not consider the cost of increased hospital stay.

Methods: This retrospective study included patients admitted to the intensive care unit at Hospital Universitario de Canarias (Tenerife, Spain) who had a subclavian venous catheter.

Results: Patients with CHSS catheters (n = 353) had a lower incidence density of CRBSI (2.12 vs 0 out of 1,000 catheter-days; P = .02) and lower CVC-related cost per catheter-day (3.35 ± 3.75 vs 3.94 ± 9.95; P = .002) than those with standard catheters (n = 518). CHSS-impregnated catheters were associated with a lower risk of CRBSI (exact logistic regression) (odds ratio, 0.10; 95% confidence interval, −∞ to 0.667; P = .008) than standard catheters when controlling for catheter duration. CHSS-impregnated catheters were also associated with a lower CVC-related cost per catheter day than standard catheters (Poisson regression) (odds ratio, 0.85; 95% confidence interval, 0.001-0.873; P < .001).

Conclusions: CHSS-impregnated catheters may be efficient in preventing CRBSI in patients with subclavian venous access.

Thank you to our partners for supporting IVTEAM

Share.

Comments are closed.

Free Email Updates
Join 5.5K IVTEAM members. Subscribe now and be the first to receive all the latest free updates from IVTEAM!
100% Privacy. We don't spam.